Lineage Cell Therapeutics, Inc.
US ˙ NYSEAM ˙ US53566P1093

Introduction

This page provides a comprehensive analysis of the known insider trading history of Mulroy Michael H.. Insiders are officers, directors, or significant investors in a company. It is illegal for insiders to make trades in their companies based on specific, non-public information. This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4. Despite these restrictions, academic research suggests that insiders - in general - tend to outperform the market in their own companies.

Average Trade Profitability

The average trade profitability is the average return of all the open market purchases made by the insider in the last three years. To calculate this, we examine every open-market, unplanned purchase made by the insider, excluding all trades that were marked as part of a 10b5-1 trading plan. We then calculate the average performance of those trades over 3, 6, and 12 months, averaging each of those durations to generate a final performance metric for each trade. Finally, we average all of the performance metrics to calculate a performance metric for the insider. This list only includes insiders that have made at least three trades in the last two years.

If this insiders trade profitability is "N/A", then the insider either has not made any open-market purchases in the last three years, or the trades they’ve made are too recent to calculate a reliable performance metric.

Update Frequency: Daily

See the list of most profitable insider traders.

Companies with Reported Insider Positions

The SEC filings indicate Mulroy Michael H. has reported holdings or trades in the following companies:

Security Title Latest Reported Holdings
US:LCTX / Lineage Cell Therapeutics, Inc. Director 298,555
US:AGE / AgeX Therapeutics, Inc. Director 65,000
President and CEO, Director 273,622
US:QCOR / EVP, Strat. Affairs & GC 0
US:CMRO / Comarco, Inc. Director 70,000
How to Interpret the Charts

The following charts show the stock performance of securities subsequent to each open-market, non-planned trade made by Mulroy Michael H.. Non-planned trade are trades that were not made as part of a 10b5-1 trading plan. The stock performance is charted as cumulative percent change in share price. For example, if an insider trade was made on January 1, 2019, the chart will show the daily percent change of the security to the present day. If the share price were to go from $10 to $15 during this time, the cumulative percent change in share price would be 50%. A change in price from $10 to $20 would be 100%, and a change in price of $10 to $5 would be -50%.

Ultimately, we are trying to determine how closely the insider’s trades correlate to excess returns (positive or negative) in the share price in order to see if the insider is timing their trades to profit from insider information. Consider the situation where an insider was doing this. In this situation, we would expect either (a) positive returns after purchases, or (b) negative returns after sales. In the case of (a), the PURCHASE chart would show a series of upwardly sloping curves, indicating positive returns after each purchase transaction. In the case of (b), the SALE chart would show a series of downward sloping curves, indicating negative returns after each sale transaction.

However, this alone is not enough to draw conclusions. If, for example, the share price of the company was in a non-cyclical climb over many years, then we would expect all the post-purchase plots to be upwardly sloping. Likewise, non-cyclical declines over many years would result in downward sloping post-trade plots. Neither of these charts would suggest insider trading activity.

The strongest indicator would be a situation where the share price was extremely cyclical, and there were both positive signals in the PURCHASE chart and negative plots on the SALE chart. This situation would be highly suggestive of an insider that was timing trades to their financial advantage.

Insider Purchases LCTX / Lineage Cell Therapeutics, Inc. - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in LCTX / Lineage Cell Therapeutics, Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Max
Price at
Max
Max
Profit ($)
Max Return (%)
2024-11-22 LCTX Mulroy Michael H. 40,000 0.5660 40,000 0.5660 22,640 293 1.2900 28,960 127.92
2022-03-24 LCTX Mulroy Michael H. 7,000 1.4000 7,000 1.4000 9,800

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

LCTX / Lineage Cell Therapeutics, Inc. Insider Trades
Insider Sales LCTX / Lineage Cell Therapeutics, Inc. - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in LCTX / Lineage Cell Therapeutics, Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Min
Price at
Min
Max Loss
Avoided ($)
Max Loss
Avoided (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

LCTX / Lineage Cell Therapeutics, Inc. Insider Trades
Insider Trading History

This table shows the complete list of insider trades made by Mulroy Michael H. as disclosed to the Securities Exchange Commission (SEC).

File Date Tran Date Form Ticker Security Code 10b5-1 Shares Remaining Shares Percent
Change
Share
Price
Tran
Value
Remaining
Value
2024-11-25 2024-11-22 4 LCTX Lineage Cell Therapeutics, Inc.
Common Shares
P - Purchase 40,000 298,555 15.47 0.57 22,640 168,982
2022-03-25 2022-03-24 4 LCTX Lineage Cell Therapeutics, Inc.
Common Shares, no par value
P - Purchase 7,000 258,555 2.78 1.40 9,800 361,977
2021-07-01 2021-07-01 4 LCTX Lineage Cell Therapeutics, Inc.
Stock Option (right to buy)
A - Award 50,000 50,000
2021-06-21 2021-06-18 4 LCTX Lineage Cell Therapeutics, Inc.
Stock Option (right to buy)
M - Exercise -24,720 0 -100.00
2021-06-21 2021-06-18 4 LCTX Lineage Cell Therapeutics, Inc.
Common Shares, no par value
M - Exercise 24,720 251,555 10.90 2.20 54,384 553,421
2020-07-02 2020-07-01 4 LCTX Lineage Cell Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award 40,000 40,000
2019-07-03 2019-07-01 4 BTX BIOTIME INC
Stock Option (Right to Buy)
A - Award 40,000 40,000
2019-03-15 2019-03-08 4 BTX BIOTIME INC
Common Shares, no par value
A - Award 194,271 226,821 596.84
2019-03-13 2019-03-11 4 AGE AgeX Therapeutics, Inc.
Option to Purchase Common Stock
A - Award 65,000 65,000
2019-03-05 2019-03-01 4 AST Asterias Biotherapeutics, Inc.
Common Stock
F - Taxes -76,588 273,622 -21.87 0.95 -72,759 259,941
2019-03-05 2019-03-01 4 AST Asterias Biotherapeutics, Inc.
Common Stock
A - Award 252,606 350,210 258.81
2018-08-29 2018-08-27 4 AST Asterias Biotherapeutics, Inc.
Common Stock
P - Purchase 3,141 97,604 3.33 1.59 5,000 155,366
2018-07-27 2018-07-25 4 AST Asterias Biotherapeutics, Inc.
Common Stock
P - Purchase 2,950 94,463 3.22 1.69 5,000 160,105
2018-07-03 2018-07-01 4 BTX BIOTIME INC
Option to Purchase Common Shares
A - Award 40,000 40,000
2018-06-27 2018-06-25 4 AST Asterias Biotherapeutics, Inc.
Common Stock
P - Purchase 3,067 91,513 3.47 1.63 4,999 149,166
2018-05-31 2018-05-25 4 AST Asterias Biotherapeutics, Inc.
Common Stock
P - Purchase 3,153 88,446 3.70 1.59 5,000 140,249
2018-04-27 2018-04-25 4 AST Asterias Biotherapeutics, Inc.
Common Stock
P - Purchase 3,752 85,293 4.60 1.33 4,990 113,440
2018-03-28 2018-03-26 4 AST Asterias Biotherapeutics, Inc.
Common Stock
P - Purchase 2,839 81,541 3.61 1.76 4,997 143,512
2018-03-19 2018-03-15 4 AST Asterias Biotherapeutics, Inc.
Stock Options
A - Award 200,000 200,000
2018-03-19 2018-03-15 4 AST Asterias Biotherapeutics, Inc.
Common Stock
F - Taxes -28,358 78,702 -26.49 1.95 -55,298 153,469
2018-03-19 2018-03-15 4 AST Asterias Biotherapeutics, Inc.
Common Stock
A - Award 94,872 107,060 778.40
2018-02-28 2018-02-26 4 AST Asterias Biotherapeutics, Inc.
Common Stock
P - Purchase 2,255 12,188 22.70 2.22 5,000 27,023
2018-01-26 2018-01-25 4 AST Asterias Biotherapeutics, Inc.
Common Stock
P - Purchase 2,134 9,933 27.36 2.34 5,000 23,273
2017-12-28 2017-12-26 4 AST Asterias Biotherapeutics, Inc.
Common Stock
P - Purchase 2,247 7,799 40.47 2.22 4,988 17,314
2017-11-29 2017-11-27 4 AST Asterias Biotherapeutics, Inc.
Common Stock
P - Purchase 2,076 5,552 59.72 2.41 5,003 13,380
2017-10-27 2017-10-25 4 AST Asterias Biotherapeutics, Inc.
Common Stock
P - Purchase 1,939 3,476 126.15 2.55 4,944 8,864
2017-09-27 2017-09-25 4 AST Asterias Biotherapeutics, Inc.
Common Stock
P - Purchase 1,537 1,537 3.25 4,997 4,997
2017-07-05 2017-07-01 4 BTX BIOTIME INC
Option to Purchase Common Shares
A - Award 20,000 20,000
2017-06-28 2017-06-26 4 AST Asterias Biotherapeutics, Inc.
Stock Options (right to buy)
A - Award 800,000 800,000
2016-07-05 2016-07-01 4 BTX BIOTIME INC
Option to Purchase Common Shares
A - Award 20,000 20,000
2015-07-06 2015-07-01 4 BTX BIOTIME INC
Option to Purchase Common Shares
A - Award 20,000 20,000
2014-10-07 3 BTX BIOTIME INC
Common Shares, no par value
65,100
2014-10-07 3 BTX BIOTIME INC
Common Shares, no par value
65,100
2014-08-18 2014-08-14 4 QCOR QUESTCOR PHARMACEUTICALS INC
Stock Option (right to buy)
D - Sale to Issuer -56,250 0 -100.00
2014-08-18 2014-08-14 4 QCOR QUESTCOR PHARMACEUTICALS INC
Stock Option (right to buy)
D - Sale to Issuer -51,979 0 -100.00
2014-08-18 2014-08-14 4 QCOR QUESTCOR PHARMACEUTICALS INC
Common Stock
D - Sale to Issuer -18,000 0 -100.00
2014-08-18 2014-08-14 4 QCOR QUESTCOR PHARMACEUTICALS INC
Common Stock
D - Sale to Issuer -39,187 0 -100.00
2014-08-18 2014-08-14 4 QCOR QUESTCOR PHARMACEUTICALS INC
Common Stock
D - Sale to Issuer -16,072 0 -100.00
2014-08-13 2014-08-11 4 QCOR QUESTCOR PHARMACEUTICALS INC
Common Stock
S - Sale -5,000 65,714 -7.07 92.32 -461,616 6,066,927
2014-08-13 2014-08-11 4 QCOR QUESTCOR PHARMACEUTICALS INC
Common Stock
S - Sale -5,000 70,714 -6.60 92.35 -461,732 6,530,176
2014-08-13 2014-08-06 4 QCOR QUESTCOR PHARMACEUTICALS INC
Common Stock
G - Gift -1,349 75,714 -1.75
2014-08-04 2014-07-31 4 QCOR QUESTCOR PHARMACEUTICALS INC
Common Stock
F - Taxes -1,304 75,759 -1.69 92.35 -120,424 6,996,344
2014-07-14 2014-07-10 4 QCOR QUESTCOR PHARMACEUTICALS INC
Stock Option (right to buy)
M - Exercise -10,000 75,000 -11.76
2014-07-14 2014-07-10 4 QCOR QUESTCOR PHARMACEUTICALS INC
Common Stock
S - Sale -5,000 77,063 -6.09 90.86 -454,324 7,002,322
2014-07-14 2014-07-10 4 QCOR QUESTCOR PHARMACEUTICALS INC
Common Stock
S - Sale -5,000 82,063 -5.74 90.92 -454,588 7,460,963
2014-07-14 2014-07-10 4 QCOR QUESTCOR PHARMACEUTICALS INC
Common Stock
M - Exercise 10,000 87,063 12.98 14.24 142,400 1,239,777
2014-06-12 2014-06-10 4 QCOR QUESTCOR PHARMACEUTICALS INC
Stock Option (right to buy)
M - Exercise -10,000 85,000 -10.53
2014-06-12 2014-06-10 4 QCOR QUESTCOR PHARMACEUTICALS INC
Common Stock
S - Sale -5,000 77,063 -6.09 88.58 -442,876 6,825,863
2014-06-12 2014-06-10 4 QCOR QUESTCOR PHARMACEUTICALS INC
Common Stock
S - Sale -5,000 82,063 -5.74 88.57 -442,869 7,268,632
2014-06-12 2014-06-10 4 QCOR QUESTCOR PHARMACEUTICALS INC
Common Stock
M - Exercise 10,000 87,063 12.98 14.24 142,400 1,239,777
2014-05-14 2014-05-12 4 QCOR QUESTCOR PHARMACEUTICALS INC
Common Stock
S - Sale -5,000 77,063 -6.09 87.97 -439,856 6,779,332
2014-05-14 2014-05-12 4 QCOR QUESTCOR PHARMACEUTICALS INC
Common Stock
S - Sale -5,000 82,063 -5.74 88.01 -440,052 7,222,389
2014-05-14 2014-05-12 4 QCOR QUESTCOR PHARMACEUTICALS INC
Common Stock
M - Exercise 10,000 87,063 12.98 14.24 142,400 1,239,777
2014-05-14 2014-04-10 4 QCOR QUESTCOR PHARMACEUTICALS INC
Stock Option (right to buy)
M - Exercise -10,000 95,000 -9.52
2014-04-14 2014-04-10 4 QCOR QUESTCOR PHARMACEUTICALS INC
Stock Option (right to buy)
M - Exercise -10,000 105,000 -8.70
2014-04-14 2014-04-10 4 QCOR QUESTCOR PHARMACEUTICALS INC
Common Stock
S - Sale -5,000 77,063 -6.09 85.03 -425,155 6,552,744
2014-04-14 2014-04-10 4 QCOR QUESTCOR PHARMACEUTICALS INC
Common Stock
S - Sale -5,000 82,063 -5.74 85.05 -425,245 6,979,376
2014-04-14 2014-04-10 4 QCOR QUESTCOR PHARMACEUTICALS INC
Common Stock
M - Exercise 10,000 87,063 12.98 14.24 142,400 1,239,777
2014-03-12 2014-03-10 4 QCOR QUESTCOR PHARMACEUTICALS INC
Stock Option (right to buy)
M - Exercise -10,000 115,000 -8.00
2014-03-12 2014-03-10 4 QCOR QUESTCOR PHARMACEUTICALS INC
Common Stock
S - Sale -2,253 77,063 -2.84 65.59 -147,776 5,054,616
2014-03-12 2014-03-10 4 QCOR QUESTCOR PHARMACEUTICALS INC
Common Stock
S - Sale -4,390 79,316 -5.24 65.07 -285,653 5,161,021
2014-03-12 2014-03-10 4 QCOR QUESTCOR PHARMACEUTICALS INC
Common Stock
S - Sale -3,357 83,706 -3.86 63.91 -214,561 5,350,036
2014-03-12 2014-03-10 4 QCOR QUESTCOR PHARMACEUTICALS INC
Common Stock
M - Exercise 10,000 87,063 12.98 14.24 142,400 1,239,777
2014-02-26 2014-02-24 4 QCOR QUESTCOR PHARMACEUTICALS INC
Common Stock
F - Taxes -12,552 77,063 -14.01 79.46 -997,382 6,123,426
2014-02-26 2014-02-24 4 QCOR QUESTCOR PHARMACEUTICALS INC
Common Stock
D - Sale to Issuer -12,167 89,615 -11.95
2014-02-26 2014-02-24 4 QCOR QUESTCOR PHARMACEUTICALS INC
Common Stock
A - Award 18,000 101,782 21.48
2014-02-26 2014-02-24 4 QCOR QUESTCOR PHARMACEUTICALS INC
Common Stock
A - Award 18,000 101,782 21.48
2013-10-10 2013-10-08 4 CMRO COMARCO INC
Common Stock
A - Award 40,000 70,000 133.33
2013-08-02 2013-07-31 4 QCOR QUESTCOR PHARMACEUTICALS INC
Common Stock
A - Award 10,000 65,782 17.93
2013-02-26 2013-02-24 4 QCOR QUESTCOR PHARMACEUTICALS INC
Common Stock
A - Award 18,250 54,260 50.68
2013-02-26 2013-02-24 4 QCOR QUESTCOR PHARMACEUTICALS INC
Common Stock
A - Award 18,250 54,260 50.68
2013-02-26 2013-02-24 4 QCOR QUESTCOR PHARMACEUTICALS INC
Common Stock
A - Award 15,643 17,760 738.92
2012-10-22 2012-10-18 4 CMRO COMARCO INC
Right to buy
A - Award 40,000 40,000
2012-05-24 2012-05-23 4 QCOR QUESTCOR PHARMACEUTICALS INC
Common Stock
P - Purchase 1,000 2,117 89.53 40.00 40,000 84,680
2012-02-17 2012-02-15 4 QCOR QUESTCOR PHARMACEUTICALS INC
Stock Option (Right to Buy)
A - Award 20,000 20,000
2012-02-17 2012-02-15 4 QCOR QUESTCOR PHARMACEUTICALS INC
Stock Option (Right to Buy)
A - Award 60,000 60,000
P
Open market or private purchase of non-derivative or derivative security
S
Open market or private sale of non-derivative or derivative security
A
Grant, award, or other acquisition of securities from the company (such as an option)
C
Conversion of derivative
D
Sale or transfer of securities back to the company
F
Payment of exercise price or tax liability using portion of securities received from the company
G
Gift of securities by or to the insider
K
Equity swaps and similar hedging transactions
M
Exercise or conversion of derivative security received from the company (such as an option)
V
A transaction voluntarily reported on Form 4
J
Other (accompanied by a footnote describing the transaction)